Association of an 11–12 kDa protease-resistant prion protein fragment with subtypes of dura graft-associated Creutzfeldt–Jakob disease and other prion diseases

References

1. Brown P., Preece M., Brandel J. P. 12 other authors 2000; Iatrogenic Creutzfeldt–Jakob disease at the millennium. Neurology 55:1075–1081
   [Google Scholar]
2. Capellari S., Parchi P., Russo C. M., Sanford J., Sy M.-S., Gambetti P., Petersen R. B. 2000; Effect of the E200K mutation on prion protein metabolism: comparative study of a cell model and human brain. Am J Pathol 157:613–622
   [Google Scholar]
3. Chen S. G., Teplow D. B., Parchi P., Teller J. K., Gambetti P., Autilio-Gambetti L. 1995; Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270:19173–19180
   [Google Scholar]
4. Collinge J., Sidle K. C. L., Meads J., Ironside J., Hill A. F. 1996; Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383:685–690
   [Google Scholar]
5. de Silva R., Ironside J. W., McCardle L. 7 other authors 1994; Neuropathological phenotype and prion protein genotype: correlation in sporadic Creutzfeldt–Jakob disease. Neurosci Lett 179:50–52
   [Google Scholar]
6. Doh-ura K., Kitamoto T., Sakaki Y., Tateishi J. 1991; CJD discrepancy. Nature 353:801–802
   [Google Scholar]
7. Fischer M., Rülicke T., Raeber A., Sailer A., Moser M., Oesch B., Brandner S., Aguzzi A., Weissmann C. 1996; Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15:1255–1264
   [Google Scholar]
8. Hoshi K., Yoshino H., Urata J., Nakamura Y., Yanagawa H., Sato T. 2000; Creutzfeldt–Jakob disease associated with cadaveric dura mater grafts in Japan. Neurology 55:718–721
   [Google Scholar]
9. Kascsak R. J., Rubenstein R., Merz P. A., Tonna-DeMasi M., Fersko R., Carp R. I., Wisniewski H. M., Diringer H. 1987; Mouse polyclonal and monoclonal antibody to scrapie-associated fibril protein. J Virol 61:3688–3693
   [Google Scholar]
10. Kimura K., Nonaka A., Tashiro H., Yaginuma M., Shimokawa R., Okeda R., Yamada M. 2001; Atypical form of dural graft associated Creutzfeldt–Jakob disease: report of a postmortem case with review of the literature. J Neurol Neurosurg Psychiatry 70:696–699
    [Google Scholar]
11. Kitamoto T., Tateishi J. 1994; Human prion diseases with variant prion protein. Philos Trans R Soc Lond Ser B Biol Sci 343:391–398
    [Google Scholar]
12. Kitamoto T., Shin R.-W., Doh-ura K., Tomokane N., Miyazono M., Muramoto T., Tateishi J. 1992; Abnormal isoform of prion protein accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt–Jakob disease. Am J Pathol 140:1285–1294
    [Google Scholar]
13. Kitamoto T., Mohri S., Ironside J. W. 9 other authors 2002; Follicular dendritic cell of the knock-in mouse provides a new bioassay for human prions. Biochem Biophys Res Commun 294:280–286
    [Google Scholar]
14. Kopp N., Streichenberger N., Deslys J. P., Laplanche J. L., Chazot G. 1996; Creutzfeldt–Jakob disease in a 52-year-old woman with florid plaques. Lancet 348:1239–1240
    [Google Scholar]
15. Lane K. L., Brown P., Howell D. N., Crain B. J., Hulette C. M., Burger P. C., DeArmond S. J. 1994; Creutzfeldt–Jakob disease in a pregnant woman with an implanted dura mater graft. Neurosurgery 34:737–739
    [Google Scholar]
16. Lang C. J. G., Heckmann J. G., Neundörfer B. 1998; Creutzfeldt–Jakob disease via dural and corneal transplants. J Neurol Sci 160:128–139
    [Google Scholar]
17. Martin J. J. 1975; Thalamic degenerations. In Handbook of Clinical Neurology vol 21 pp  587–604 Edited by Vinken P. J., Bruyn G. W. Amsterdam: North-Holland;
    [Google Scholar]
18. Miyashita K., Inuzuka T., Kondo H. 7 other authors 1991; Creutzfeldt–Jakob disease in a patient with a cadaveric dural graft. Neurology 41:940–941
    [Google Scholar]
19. Miyazono M., Kitamoto T., Doh-ura K., Iwaki T., Tateishi J. 1992; Creutzfeldt–Jakob disease with codon 129 polymorphism (valine): a comparative study of patients with codon 102 point mutation or without mutations. Acta Neuropathol 84:349–354
    [Google Scholar]
20. Muramoto T., Tanaka T., Kitamoto N., Sano C., Hayashi Y., Kutomi T., Yutani C., Kitamoto T. 2000; Analyses of Gerstmann–Straussler syndrome with 102Leu219Lys using monoclonal antibodies that specifically detect human prion protein with 219Glu. Neurosci Lett 288:179–182
    [Google Scholar]
21. Parchi P., Castellani R., Capellari S. 9 other authors 1996; Molecular basis of phenotypic variability in sporadic Creutzfeldt–Jakob disease. Ann Neurol 39:767–778
    [Google Scholar]
22. Parchi P., Capellari S., Chen S. G. 8 other authors 1997; Typing prion isoforms. Nature 386:232–234
    [Google Scholar]
23. Parchi P., Chen S. G., Brown P. 9 other authors 1998; Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann–Sträussler–Scheinker disease. Proc Natl Acad Sci U S A 95:8322–8327
    [Google Scholar]
24. Parchi P., Giese A., Capellari S. 15 other authors 1999; Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233
    [Google Scholar]
25. Parchi P., Zou W., Wang W. 10 other authors 2000; Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A 97:10168–10172
    [Google Scholar]
26. Radbauer C., Hainfellner J. A., Gaudernak T., Deecke L., Budka H. 1998; Creutzfeldt–Jakob disease in a dura transplant recipient: first observation in Austria. Wien Klin Wochenschr 110:496–500
    [Google Scholar]
27. Shimizu S., Hoshi K., Muramoto T., Homma M., Ironside J., Kuzuhara S., Sato T., Yamamoto T., Kitamoto T. 1999; Creutzfeldt–Jakob disease with florid-type plaques after cadaveric dura mater grafting. Arch Neurol 56:357–362
    [Google Scholar]
28. Shmerling D., Hegyi I., Fischer M. 10 other authors 1998; Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93:203–214
    [Google Scholar]
29. Supattapone S., Muramoto T., Legname G., Mehlhorn I., Cohen F. E., DeArmond S. J., Prusiner S. B., Scott M. R. 2001; Identification of two prion protein regions that modify scrapie incubation time. J Virol 75:1408–1413
    [Google Scholar]
30. Tagliavini F., Prelli F., Ghiso J., Bugiani O., Serban D., Prusiner S. B., Farlow M. R., Ghetti B., Frangione B. 1991; Amyloid protein of Gerstmann–Sträussler–Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58. EMBO J 10:513–519
    [Google Scholar]
31. Tagliavini F., Lievens P. M.-J., Tranchant C. 12 other authors 2001; A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann–Sträussler–Scheinker disease A117V. J Biol Chem 276:6009–6015
    [Google Scholar]
32. Takahashi S., Tateishi J., Taguchi Y., Hirade S., Inoue H., Matsui Y., Furukawa H. 1997; Creutzfeldt–Jakob disease with a widespread presence of kuru-type plaques after cadaveric dural graft replacement: an autopsy case. Rinsho Shinkeigaku 37:824–828 (in Japanese
    [Google Scholar]
33. Takashima S., Tateishi J., Taguchi Y., Inoue H. 1997; Creutzfeldt–Jakob disease with florid plaques after cadaveric dural graft in a Japanese woman. Lancet 350:865–866
    [Google Scholar]
34. Thadani V., Penar P. L., Partington J., Kalb R., Janssen R., Schonberger L. B., Rabkin C. S., Prichard J. W. 1988; Creutzfeldt–Jakob disease probably acquired from a cadaveric dura mater graft. J Neurosurg 69:766–769
    [Google Scholar]
35. Yamada S., Aiba T., Endo Y., Hara M., Kitamoto T., Tateishi J. 1994; Creutzfeldt–Jakob disease transmitted by a cadaveric dura mater graft. Neurosurgery 34:740–743
    [Google Scholar]
36. Yamada M., Itoh Y., Suematsu N., Matsushita M., Otomo E. 1997; Panencephalopathic type of Creutzfeldt–Jakob disease associated with cadaveric dura mater graft. J Neurol Neurosurg Psychiatry 63:524–527
    [Google Scholar]